INFLAMMATIX Trademark

Trademark Overview

On Thursday, March 15, 2018, a trademark application was filed for INFLAMMATIX with the United States Patent and Trademark Office. The USPTO has given the INFLAMMATIX trademark a serial number of 87835880. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by Inflammatix, Inc.. The INFLAMMATIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical diagnostic reagents for use in analysis of gene expression tests, gene expression profiling assays, analyzing genetic information, analysis of biomarker levels and/or for use in analyzing relative expressions of host response

Medical research, namely, development of rapid medical tests and molecular diagnostic tests using bioinformatics, algorithms, and machine learning, development of medical tests based on the immune system and immune responses, gene expression, genetic information, demographic information and/or clinical data, for medical purposes
inflammatix

General Information

Serial Number87835880
Word MarkINFLAMMATIX
Filing DateThursday, March 15, 2018
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6760579
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements

Goods and ServicesMedical diagnostic reagents for use in analysis of gene expression tests, gene expression profiling assays, analyzing genetic information, analysis of biomarker levels and/or for use in analyzing relative expressions of host response
Goods and ServicesMedical research, namely, development of rapid medical tests and molecular diagnostic tests using bioinformatics, algorithms, and machine learning, development of medical tests based on the immune system and immune responses, gene expression, genetic information, demographic information and/or clinical data, for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 4, 2019
Primary Code005
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 22, 2018
Primary Code042
First Use Anywhere DateMonday, November 30, 2015
First Use In Commerce DateMonday, November 30, 2015

Trademark Owner History

Party NameInflammatix, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085
Party NameInflammatix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085
Party NameInflammatix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010

Trademark Events

Event DateEvent Description
Wednesday, June 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, May 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 6, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 4, 2022USE AMENDMENT FILED
Wednesday, May 4, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, April 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 4, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, March 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 5, 2021SOU EXTENSION 5 GRANTED
Wednesday, November 3, 2021SOU EXTENSION 5 FILED
Wednesday, November 3, 2021TEAS EXTENSION RECEIVED
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 22, 2021SOU EXTENSION 4 GRANTED
Friday, May 7, 2021SOU EXTENSION 4 FILED
Thursday, June 17, 2021NOTICE OF REVIVAL - E-MAILED
Thursday, June 17, 2021EXTENSION RECEIVED WITH TEAS PETITION
Thursday, June 17, 2021PETITION TO REVIVE-GRANTED
Thursday, June 17, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, June 7, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 7, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 6, 2020SOU EXTENSION 3 GRANTED
Friday, November 6, 2020SOU EXTENSION 3 FILED
Friday, November 6, 2020TEAS EXTENSION RECEIVED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020SOU EXTENSION 2 GRANTED
Thursday, May 7, 2020SOU EXTENSION 2 FILED
Thursday, May 7, 2020TEAS EXTENSION RECEIVED
Saturday, March 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2020SOU EXTENSION 1 GRANTED
Thursday, November 7, 2019SOU EXTENSION 1 FILED
Thursday, March 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 4, 2020NOTICE OF REVIVAL - E-MAILED
Monday, February 3, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, February 3, 2020PETITION TO REVIVE-GRANTED
Monday, February 3, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, December 9, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 9, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 6, 2019ASSIGNED TO LIE
Wednesday, January 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 26, 2018ASSIGNED TO EXAMINER
Thursday, March 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 19, 2018NEW APPLICATION ENTERED

Related Keywords

inflammatix medical tests expression gene information analysis diagnostic immune analyzing genetic